home / stock / avhhl / avhhl quote
Last: | $1.77 |
---|---|
Change Percent: | 0.0% |
Open: | $1.77 |
Close: | $1.77 |
High: | $1.77 |
Low: | $1.77 |
Volume: | 250 |
Last Trade Date Time: | 05/06/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.77 | $1.77 | $1.77 | $1.77 | $1.77 | 250 | 05-06-2024 |
$1.53 | $1.53 | $1.53 | $1.53 | $1.53 | 100 | 04-26-2024 |
$2.1 | $0 | $2.1 | $0 | $0 | 15 | 04-19-2024 |
$2.1 | $0 | $2.1 | $0 | $0 | 55 | 04-16-2024 |
$2.1 | $2.1 | $2.1 | $2.1 | $2.1 | 100 | 04-15-2024 |
$3.2 | $3.2 | $3.2 | $3.2 | $3.2 | 100 | 03-29-2024 |
$3.2 | $3.2 | $3.2 | $3.2 | $3.2 | 100 | 03-28-2024 |
$3.2 | $3.2 | $3.2 | $3.2 | $3.2 | 600 | 03-25-2024 |
$3.203 | $0 | $3.203 | $0 | $0 | 7 | 03-20-2024 |
$3.203 | $3.203 | $3.203 | $3.203 | $3.203 | 650 | 03-07-2024 |
$2.95 | $2.95 | $2.95 | $2.95 | $2.95 | 666 | 02-23-2024 |
$3.22 | $0 | $3.22 | $0 | $0 | 10 | 02-20-2024 |
$3.22 | $3.22 | $3.22 | $3.22 | $3.22 | 100 | 02-15-2024 |
$3.2 | $3.2 | $3.2 | $3.2 | $3.2 | 330 | 02-13-2024 |
$3.28 | $3.28 | $3.28 | $3.28 | $3.28 | 2,000 | 02-06-2024 |
$3.45 | $3.24 | $3.45 | $3.45 | $3.1 | 1,275 | 02-02-2024 |
$3.1 | $3.1 | $3.1 | $3.1 | $3.1 | 3,925 | 01-30-2024 |
$2.89 | $2.94 | $2.89 | $2.94 | $2.89 | 884 | 01-29-2024 |
$2.77 | $2.77 | $2.77 | $2.77 | $2.77 | 400 | 01-04-2024 |
$2.72 | $2.72 | $2.72 | $2.72 | $2.72 | 2,600 | 01-02-2024 |
News, Short Squeeze, Breakout and More Instantly...
Avita Therapeutics Company Name:
AVHHL Stock Symbol:
OTCMKTS Market:
VALENCIA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that it will report its first quarter 2024 financia...
VALENCIA, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced an update to its expected commercial revenue for th...
VALENCIA, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced it has submitted its response to the U.S. Food and D...